ストックスクリーナーアプリを入手
10.24
0.59%
0.06
Iteos Therapeutics Inc (ITOS) 最新ニュース
Nuveen Asset Management LLC Trims Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
iteos therapeutics announces board resignation - Investing.com
Tim Van Hauwermeiren Resigns from iTeos Board - TipRanks
Deutsche Bank AG Sells 14,418 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Long Term Trading Analysis for (ITOS) - news.stocktradersdaily.com
Layoff Tracker: Keros Cuts 45% of Workforce Along With Pulmonary Hypertension Drug - BioSpace
Q2 EPS Forecast for iTeos Therapeutics Decreased by Analyst - Defense World
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Position Increased by Ameriprise Financial Inc. - Defense World
iTeos Therapeutics (ITOS) Upgraded to Buy: Here's What You Should Know - MSN
Wedbush Lowers Earnings Estimates for iTeos Therapeutics - Defense World
Rx Rundown: Novartis, iTeos Therapeutics, Moderna and more - Medical Marketing and Media
iTeos Therapeutics Stock Jumps Following Operational Closure Announcement - MSN
All Over For iTeos But Applause For Plan To Return Cash Fast - insights.citeline.com
iTeos to shut down operations after TIGIT setback and GSK exit - The Pharma Letter
iTeos Therapeutics (NASDAQ:ITOS) Receives “Equal Weight” Rating from Wells Fargo & Company - Defense World
iTeos Therapeutics to wind down operations, explore asset sales By Investing.com - Investing.com South Africa
Fierce Biotech Layoff Tracker 2025: Keros cuts 70 jobs; iTeos winds down - Fierce Biotech
iTeos Therapeutics (NASDAQ:ITOS) Lowered to “Neutral” Rating by Wedbush - Defense World
Wedbush cuts iTeos stock rating, raises PT to $12 from $10 - Investing.com Canada
Drug developer iTeos to shut down operations after cancer therapy setback - 1470 & 100.3 WMBD
Cancer drugmaker iTeos to shut down - BioPharma Dive
iTeos Therapeutics To Wind Down Operations, Explores Asset Sale: Retail Believes It’s ‘Worth More Selling It Off’ - Investing.com India
iTeos Therapeutics stock surges on wind-down news By Investing.com - Investing.com Canada
Watertown immuno-oncology biotech winds down operations - The Business Journals
iTeos Therapeutics (ITOS) Downgraded by Wells Fargo with Revised Price Target | ITOS Stock News - GuruFocus
iTeos Therapeutics (ITOS) Faces Downgrade Amid Operational Changes | ITOS Stock News - GuruFocus
ITeos Therapeutics (ITOS) Sees Downgrade and Target Price Cut | - GuruFocus
ITeos Therapeutics (ITOS) Sees Downgrade and Target Price Cut | ITOS Stock News - GuruFocus
iTeos Therapeutics stock surges on wind-down news - Investing.com
ITeos Therapeutics (ITOS) Receives Analyst Downgrade from Wedbus - GuruFocus
iTeos Therapeutics (ITOS) Downgraded as Company Plans Operationa - GuruFocus
Wedbush Downgrades iTeos Therapeutics (ITOS) Rating to Neutral | - GuruFocus
I Teos Therapeutics Inc Expected Severance Costs Of $21.8 Million To $24.7 Million - marketscreener.com
ITeos Therapeutics (ITOS) Receives Analyst Downgrade from Wedbush | ITOS Stock News - GuruFocus
Wedbush Downgrades iTeos Therapeutics to Neutral From Outperform, Adjusts Price Target to $12 From $10 - marketscreener.com
iTeos Therapeutics (ITOS) to Cease Operations and Explore Strate - GuruFocus
iTeos Therapeutics (ITOS) Shares Surge on Plans to Cease Operati - GuruFocus
iTeos Therapeutics (ITOS) to Wind Down Operations, Focus on Shar - GuruFocus
Drug developer iTeos winds down after cancer therapy setback - marketscreener.com
iTeos Therapeutics (ITOS) to Wind Down Operations, Focus on Shareholder Value | ITOS Stock News - GuruFocus
iTeos Therapeutics Announces Strategic Wind Down Plan - TipRanks
ITeos Therapeutics to Wind Down Operations - marketscreener.com
iTeos stock surges on plans to end operations (ITOS:NASDAQ) - Seeking Alpha
iTeos Therapeutics to wind down operations, explore asset sales - Investing.com
iTeos Therapeutics Announces Its Intention to Wind Down Operations - GlobeNewswire
iTeos Therapeutics Announces Intent to Wind Down Operations and Explore Asset Sales to Maximize Shareholder Value - Nasdaq
ITeos plans to shut down operations after cancer therapy setback - marketscreener.com
iTeos plans to shut down operations after cancer therapy setback - TradingView
iTeos Therapeutics Winds Down Operations: Key Assets EOS-984 and EOS-215 Up for Sale - Stock Titan
D. E. Shaw & Co. Inc. Cuts Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Northern Trust Corp Acquires 7,881 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
60,079 Shares in iTeos Therapeutics, Inc. (NASDAQ:ITOS) Purchased by BNP Paribas Financial Markets - Defense World
(ITOS) Trading Advice - news.stocktradersdaily.com
Balyasny Asset Management L.P. Buys Shares of 28,350 iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Q2 Earnings Forecast for ITOS Issued By Leerink Partnrs - Defense World
1.30%
3.35%
大文字化:
|
ボリューム (24 時間):